In November 2022, Eli Lilly’s stock price dropped dramatically after a tweet from a fake account falsely claimed that the company was making insulin free.
a series of price cuts that would lower the price of the most commonly used forms of its insulin by 70 percent. The company will also cap the out-of-pocket cost of insulin at $35 per month for those who have commercial insurance and use participating pharmacies., which caps out-of-pocket costs at $35 or less per month for people who are uninsured.
As of May 1, the company says it will drop the list price of its non branded insulin to $25 a vial from its current list price of $82.41 for a vial.s, during the fourth quarter of 2023. Humalog is the company’s most commonly prescribed insulin and the list price for one vial is currently $274.70 and the new price cuts will drop that down to $66.40.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocketThe moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for insulin they need in order to live.
Read more »
Eli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocketThe moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for insulin they need in order to live.
Read more »
Biden praises Eli Lilly for capping insulin price at $35President Biden hailed Eli Lilly & Co. on Wednesday for capping out-of-pocket costs for insulin at $35, a move that aligns with a key priority for the administration.
Read more »
'A tremendous effort': Eli Lilly to slash the price of insulin drugs to $35'It is not uncommon for a patient to come in with uncontrolled hyperglycemia, sugars, elevated to dangerous levels just because they can't afford insulin.'
Read more »
Eli Lilly caps the cost of insulin at $35 a monthThe move puts the drugmaker in line with a popular provision in the Inflation Reduction Act that capped the medication’s cost for seniors on Medicare.
Read more »